HRMY FY 2021 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$305M+91.2% YoY

Gross Profit

$250M81.8% margin

Operating Income

$88M28.7% margin

Net Income

$35M11.3% margin

EPS (Diluted)

$0.58

Cash Flow

Operating Cash Flow

$99M

Free Cash Flow

$98M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$433M

Total Liabilities

$247M

Stockholders' Equity

$187M

Cash & Equivalents

$234M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$305M	$160M	+91.2%
Gross Profit	$250M	$132M	+89.3%
Operating Income	$88M	$17M	+415.3%
Net Income	$35M	-$37M	+193.6%